Alto Neuroscience ANRO Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Alto Neuroscience’s reported figures.
Based on the most recent quarter.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Alto Neuroscience's debt-to-equity?
- Alto Neuroscience (ANRO) reported debt-to-equity of 0.1× in Q1 2026.
- How has Alto Neuroscience's debt-to-equity changed year-over-year?
- Alto Neuroscience's debt-to-equity decreased by 52.7% year-over-year, from 0.2× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.